At 6 weeks, the mean decrease in OCD severity was greater in the IVIG cohort than in placebo, but this difference did not reach statistical significance.
← all excerpts
Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies.
1
—
—